RAPT Therapeutics, Inc. (RAPT) Current Assets (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Current Assets for 5 consecutive years, with $102.6 million as the latest value for Q3 2024.
- Quarterly Current Assets fell 45.18% to $102.6 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $102.6 million through Sep 2024, down 45.18% year-over-year, with the annual reading at $161.8 million for FY2023, 35.98% down from the prior year.
- Current Assets hit $102.6 million in Q3 2024 for RAPT Therapeutics, down from $120.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $252.7 million in Q4 2022 to a low of $102.6 million in Q3 2024.
- Historically, Current Assets has averaged $171.6 million across 5 years, with a median of $175.7 million in 2022.
- Biggest five-year swings in Current Assets: soared 71.2% in 2022 and later tumbled 45.18% in 2024.
- Year by year, Current Assets stood at $115.6 million in 2020, then surged by 66.93% to $193.0 million in 2021, then surged by 30.95% to $252.7 million in 2022, then tumbled by 35.98% to $161.8 million in 2023, then plummeted by 36.58% to $102.6 million in 2024.
- Business Quant data shows Current Assets for RAPT at $102.6 million in Q3 2024, $120.5 million in Q2 2024, and $148.4 million in Q1 2024.